CAR designs combine CD28H signaling with additional immune-signaling domains in T or NK cells for cancer treatment approaches.
Patent application: #US20260306544 | #HHS #CellTherapy
@interestingpatents.bsky.social
@interestingpatents.bsky.social
@interestingpatents.bsky.socialCAR designs combine CD28H signaling with additional immune-signaling domains in T or NK cells for cancer treatment approaches.
Patent application: #US20260306544 | #HHS #CellTherapy